International Journal of Cancer · 2004 · 51 citations · 41 references
Life SciencesImmunologyMolecular BiologyGene ExpressionMolecular VirologyTranscriptional RegulationAntiviral ImmunityImmune Cell SignalingImmune Gene RegulationImmune RegulationInnate Immune ResponseInnate Immune Signaling PathwaysImmunomodulatory EffectsMrna Stability ControlPromoter ActivationTranscript StabilityTranscript Stability ControlTranscriptional ActivationViral Immune ModulationViral Mrna Stability
The latent membrane protein 1 (LMP1) of Epstein-Barr Virus (EBV) is the main inducer of immuno-modulatory molecules affecting growth and survival of EBV-infected cells. However, the network of signalling pathways involved remains to be elucidated. Here we show that LMP1 may regulate cellular genes like IFN-gamma-inducible protein-10 kDa (IP-10) not only through transcriptional but also post-transcriptional mechanisms. LMP1-mediated IP-10 expression is independent from IFN-gamma, TNF-alpha or IL-18. Transcriptional activation of IP-10 by LMP1 or CD40 stimulation depends on an NF-kappaB motif within the proximal 435 bp fragment. Carboxy-terminal activating regions 1 or 2 of LMP1 are sufficient to direct IP-10 promoter activation. IP-10 induction is inhibited by blockade of p38/SAPK2 with SB 202190, which results in decreased IP-10 mRNA half-life without affecting IP-10 promoter activity. Thus, LMP1-mediated p38/SAPK2 activation regulates transcript stability. This new mechanism of gene regulation demonstrates the potential of the oncoprotein LMP1 to orchestrate a network of signalling pathways at different regulatory levels including mRNA stability.
41
Odile Devergne, Eudoxia Hatzivassiliou, Kenneth M. Izumi et al. · Molecular and Cellular Biology · 1996 · 499 citations · Full text
Jonathan L. E. Dean, Matthew Brook, Andrew R. Clark et al. · Journal of Biological Chemistry · 1999 · 492 citations · Full text
David Huen, S A Henderson, Debbie Croom-Carter et al. · PubMed · 1995 · 463 citations